Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture Hepatotoxicity from Checkpoint Inhibitors, Biologicals, Small Molecules
Recorded On: 11/16/2020
Already registered?
Sign in now.
Biologic drugs are commonly prescribed for autoimmune conditions and malignancies. How do we manage biologicsâ effect on the liver? Acute liver failure has been reported in some patients on TNF-alpha inhibitors. Checkpoint inhibitors that modulate T-cell immune reactivity in cancer are frequently associated with liver injury. This session explores monitoring of liver tests, therapy cessation, corticosteroids and other hot topics.